No price history available.
Key financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKDm | 531 | 830 | 842 | 977 | 983 | 981 | N/A | N/A |
| Operating profit | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | HKDm | 28 | 170 | 67 | 110 | 68 | 81 | N/A | N/A |
| EPS reported | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Water Oasis Group Limited operates as an investment holding company primarily focused on providing a diverse range of beauty and wellness services, segmented into Product and Service divisions. The company delivers general, specialist, and medical beauty treatments to a broad clientele, encompassing high-end, mid-range, and mass-market consumers, catering to both men and women. Beyond its core beauty offerings, it also manages an online floral shop under the Oasis Florist brand and a manicure business named Oasis Nail. In terms of products, Water Oasis develops and markets its own skincare lines, Glycel and Eurobeauté, alongside its medical beauty brand, DermaSynergy. Furthermore, it engages in the retail and distribution of third-party skincare products from brands like Erno Laszlo and H2O+. The group's activities also extend to online skincare sales, the provision of beauty equipment, property holding, and the production and sale of cold-pressed fruit juice. As of September 30, 2021, the company operated 17 Oasis Beauty centers in Hong Kong (including 15 Oasis Beauty and 2 Oasis Homme locations) and 3 company-managed Oasis Beauty centers in Beijing, People's Republic of China. Established in 1998, Water Oasis Group Limited is headquartered in Causeway Bay, Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Water Oasis Group Limited (1161.HK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Water Oasis Group Limited operates as an investment holding company primarily focused on providing a diverse range of beauty and wellness services, segmented into Product and Service divisions. The company delivers general, specialist, and medical beauty treatments to a broad clientele, encompassing high-end, mid-range, and mass-market consumers, catering to both men and women. Beyond its core beauty offerings, it also manages an online floral shop under the Oasis Florist brand and a manicure business named Oasis Nail. In terms of products, Water Oasis develops and markets its own skincare lines, Glycel and Eurobeauté, alongside its medical beauty brand, DermaSynergy. Furthermore, it engages in the retail and distribution of third-party skincare products from brands like Erno Laszlo and H2O+. The group's activities also extend to online skincare sales, the provision of beauty equipment, property holding, and the production and sale of cold-pressed fruit juice. As of September 30, 2021, the company operated 17 Oasis Beauty centers in Hong Kong (including 15 Oasis Beauty and 2 Oasis Homme locations) and 3 company-managed Oasis Beauty centers in Beijing, People's Republic of China. Established in 1998, Water Oasis Group Limited is headquartered in Causeway Bay, Hong Kong.